The document discusses principles for maintaining confidentiality in clinical trials, including: 1. Privacy, confidentiality, and anonymity of participant data should be protected according to regulatory requirements. 2. Personally identifiable participant data is kept confidential via informed consent agreements. 3. Breaches of confidentiality pose risks to participants and only essential information should be collected with consent.